FDA’s Regulation of Veterinary Regenerative Medicine is a webinar that covers topics such as:
- Biotherapeutic products intended for commercialization
- Veterinary cellular and tissue products
- FDA`s currently regulation of human cellular and tissue products products
- FDA`s regulation of veterinary regenerative medicine
- The potential for a drug / non-drug distinction
- The new animal drug approval process
- Strategies for mitigating FDA enforcement risks
FDA’s Regulation of Veterinary Regenerative Medicine brings together:
- Professors
- Regulatory Affairs Professionals
- Consultants
- Managers
- Research Analysts
- Scientists
- Insurers focusing on Representations & Warranties Insurance
- State Policy Officials
- Venture Capitalists
- Investment Analysts
- Financial analysts and investors watching the pharmaceutical, life sciences and biotech industries
- Stem Cell Companies, Biotech, Animal Drug Companies, Pharmaceutical Companies, Veterinarians, Veterinary Hospitals and Clinics
